P e r s o n a l A c c o u n t
T H E C H E M I C A L R E C O R D
esters, azido esters, hydroxylated amino acids, fluorinated cross-metathesis (CM) in the presence of Hoveyda-Grubbs 2
amino esters, orthogonally protected amino esters, alkenylated catalyst (HG-2) in refluxing CH2Cl2 (Scheme 1).[12b]
amino esters, various heterocycles or aryl-substituted amino
A similar behavior was observed in the case of larger ring
esters.[1a,b,11] The strategy involved further selective trans- systems of lactam derivatives. Cyclooctene-fused β-lactam
formations of the cycloalkene-fused β-lactams through their regioisomers (�)-7 and (�)-11, derived from cyclooctadienes
ring C=C bond.
6 and 10 through CSI cycloaddition, could also be converted
Due to ring strain, unsaturated β-lactam (�)-2, synthetized across ROM followed by CM to the corresponding function-
by CSI cycloaddition to norbornadiene across its ring CÀ C alized azetidinone isomers (�)-8, (�)-9, (�)-12, and (�)-13
double bond, easily suffered ring cleavage under the condition (Scheme 2).[12b]
of ring-opening metathesis (ROM) in the presence of Grubbs-
It should be noted that dialkenylated β-lactam derivatives
1 catalyst (G-1), and provided divinyl-substituted lactam (�)- described above were easily transformed into the corresponding
3. Next, azetidinone derivative (�)-3 afforded the correspond- functionalized β-amino acid derivatives.[12b]
ing dicoupled derivatives (�)-4 and (�)-5 in the reaction with
The ROM/CM protocol was effectively applied to the
methyl vinyl ketone or methyl acrylate, respectively, through access of some dialkenylated cyclopentane β-amino ester
isomers as well. An illustrative example is depicted in
Loránd Kiss completed his Ph.D. in 2002
in the Department of Organic Chemistry
at the Faculty of Sciences, Debrecen
University (Debrecen, Hungary) under the
supervision of Prof. Sándor Antus. In
2003, he joined the research team of
Professor Ferenc Fülöp at the Institute of
Pharmaceutical Chemistry, University of
Szeged (Szeged, Hungary), where he
started to work in the area of cyclic β-
amino acid chemistry. He followed post-
doctoral research in the laboratories of
Prof. Norbert De Kimpe at Ghent Uni-
versity (Ghent, Belgium), and Prof. Santos
Fustero, at the Department of Organic
Chemistry, University of Valencia (Valen-
cia, Spain). He has published more than
100 scientific papers in reputed journals.
He is currently professor and department
head at the Institute of Pharmaceutical
Chemistry, University of Szeged. His
scientific interest is directed towards the
selective functionalization β-amino acid
derivatives and on the synthesis of highly
functionalized fluorinated building blocks.
University of Szeged, and between 1998
and 2017 was the head of the Institute.
He is a member of the Hungarian Acad-
emy of Sciences and has a wide range of
research interests in synthetic organic
chemistry. His recent activities have fo-
cused on the use of amino alcohols and β-
amino acids in enzymatic transformations,
various asymmetric syntheses, foldamer
construction, and flow chemistry, in view
of the development of pharmacologically
active derivatives.
Attila M. Remete graduated as chemist in
2014 from University of Szeged (Hun-
gary). He has been working at the Institute
of Pharmaceutical Chemistry, University
of Szeged since 2010. In 2014 he started
his Ph.D. under the supervision of Loránd
Kiss and received his degree in 2019. He is
currently assistant lecturer and his recent
topic focuses on the preparation of highly
substituted fluorinated building elements
from β-amino acid derivatives.
Zsanett Benke graduated as chemist in
2017 from University of Szeged, Faculty
of Science and Informatics (Hungary). In
2017 she started her Ph.D. at the Institute
of Pharmaceutical Chemistry, University
of Szeged (Hungary) under the supervision
of Loránd Kiss. Her Ph.D. topic focuses
on the selective transformations of cyclo-
alkadienes into highly functionalized
three-dimensional molecules.
Ferenc Fülöp was born in Szank, Hungary
in 1952. He received his MSc degree in
Chemistry in 1975 and his Ph.D. in 1979
from József Attila University, Szeged,
Hungary. At the beginning of his carrier
he worked in Chinoin Pharmaceuticals,
Budapest for six years. In 1991, he was
appointed as a full professor at the
Institute of Pharmaceutical Chemistry,
Chem. Rec. 2020, 20, 1–14
© 2020 The Chemical Society of Japan & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Wiley Online Library
3